Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yun-Ze Xu"'
Autor:
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Jun-Hang Luo
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Integrating genomics and histology for cancer prognosis demonstrates promise. Here, we develop a multi-classifier system integrating a lncRNA-based classifier, a deep learning whole-slide-image-based classifier, and a clinicopathological cla
Externí odkaz:
https://doaj.org/article/c0dc0f9c92514591b5800e5499188a06
Autor:
Liang Zheng, Zi-Ran Zhu, Tal Sneh, Wei-Tuo Zhang, Zao-Yu Wang, Guang-Yu Wu, Wei He, Hong-Gang Qi, Hang Wang, Xiao-Yu Wu, Jonatan Fernández-García, Ifat Abramovich, Yun-Ze Xu, Jin Zhang, Eyal Gottlieb
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 11 (2023)
Germline or somatic loss-of-function mutations of fumarate hydratase (FH) predispose patients to an aggressive form of renal cell carcinoma (RCC). Since other than tumor resection there is no effective therapy for metastatic FH-deficient RCC, an accu
Externí odkaz:
https://doaj.org/article/51f5dd7680194b299e820a073655c7da
Publikováno v:
Transactions of Nonferrous Metals Society of China. 31:3205-3227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e03d5764165d9a7ce2674c5a61944d4
https://doi.org/10.1016/s1003-6326(21)65727-8
https://doi.org/10.1016/s1003-6326(21)65727-8
Autor:
Jia-Yan, Sheng, Hong-Chao, He, Yu, Zhu, Yu-Xuan, Wu, Zhou-Jun, Shen, Ju-Ping, Zhao, Gui, Ma, Yun-Ze, Xu
Publikováno v:
Chinese medical journal. 125(9)
Myxoid adrenocortical neoplasms are rare. Surgical resection of the mass is the first-line therapy. Here we reported a total of four patients, aged 44–66 years, diagnosed with myxoid adrenocortical tumor. The clinical characteristics and immunohist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6887314576724f56c8d83d051add0881
https://pubmed.ncbi.nlm.nih.gov/22800844
https://pubmed.ncbi.nlm.nih.gov/22800844
Publikováno v:
Anti-cancer agents in medicinal chemistry. 13(2)
Adrenocortical carcinoma (ACC) is a rare but typically aggressive malignancy. Radical surgery remains the potentially curative option. However, about one third of patients initially present with distant metastases. Regarding to chemotherapy, mitotane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ed169b1e6518a94fecd95f10bb126e
https://pubmed.ncbi.nlm.nih.gov/22934700
https://pubmed.ncbi.nlm.nih.gov/22934700